Liver damage from edibles?
- Thread starter DOOM
- Start date
I'd be interested in hearing more study wise, but I am gonna say I doubt very much you would have long term health issues. It's been consumed by man for a long time...and of all the reasons the gov tries to convince you not to use, I have never heard liver mentioned.
That being said, I am sure if your liver is already compromised you may want to consult your doc. Otherwise, I am sure it is alot easier on your liver than most prescription meds.
Edit: And for the record, I would rather eat herb than take a tylenol any day...that shit will kill your liver.
That being said, I am sure if your liver is already compromised you may want to consult your doc. Otherwise, I am sure it is alot easier on your liver than most prescription meds.
Edit: And for the record, I would rather eat herb than take a tylenol any day...that shit will kill your liver.
DOOM
Well-Known Member
This.
DOOM
Well-Known Member
Edibles pretty much solve my severe ADD for up to 10 hours a day/
I plan to sit with gastroenterologist in 2 weeks to go over all this. I have severe ADD and adderral and ritalin made me feel like shit and would never think about taking it again, ever.
I'm a fucking programming workhorse with lite edibles. Vaping is great but not an option at my office.
I plan to sit with gastroenterologist in 2 weeks to go over all this. I have severe ADD and adderral and ritalin made me feel like shit and would never think about taking it again, ever.
I'm a fucking programming workhorse with lite edibles. Vaping is great but not an option at my office.
WaterBongs
New Member
It is beneficial. It regulates the entire digestive system.
http://www.michiganmedicalmarijuanaclub.org/Grannys List January 2013.pdf
--
The endocannabinoid system in chronic liver disease (full
2005)
http://www.medigraphic.com/pdfs/hepato/ah-2005/ah054c.pdf
(Marijuana/Hash) Endocannabinoids and liver disease
review (full 2005)
http://www.natap.org/2005/HCV/091905_01.htm
Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and
contributes to diet induced obesity
(full 2005)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1087161/?tool=pmcentrez
Roles of anandamide in the hepatic microcirculation in cirrhotic rats
(full 2005)
http://ajpgi.physiology.org/content/290/2/G328.full?sid=c16d770d-cd17-48c9-bbde-26f38f5eeb67
The Ffa Receptor Gpr40 Links Hyperinsulinemia, Hepatic Steatosis, and Impaired Glucose Homeostasis in Mouse.
(abst 2005)
http://www.ncbi.nlm.nih.gov/pubmed/16054069
Antifibrogenic role of the cannabinoid receptor CB2 in the liver.
(abst 2005)
http://www.ncbi.nlm.nih.gov/pubmed/15765409
CB2 receptors as new therapeutic targets for liver diseases (full 2007)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219531/?tool=pubmed
Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion
injury by attenuating oxidativestress, inflammatory response, and apoptosis
(full 2007)
http://www.jleukbio.org/cgi/content/full/82/6/1382
Cannabinoids ameliorate cerebral dysfunction following liver failure via AMP-activatedprotein kinase
(full 2007)
http://hmg.oxfordjournals.org/cgi/content/full/14/22/3389
Endocannabinoids acting at CB1 receptors mediate the cardiac contractile dysfunction invivo in cirrhotic rats
(full 2007)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2225474/?tool=pmcentrez
Pivotal Advance: Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis (full 2007)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2225476/?tool=pmcentrez
Anandamide inhibits cholangiocyte hyperplastic proliferation via activation of
thioredoxin 1/redox factor 1 and AP-1 activation (full 2007)
http://ajpgi.physiology.org/content/294/2/G506.full
Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury
(full 2007)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228252/?tool=pmcentrez
Cannabinoid receptors as new targets of antifibrosing strategies during chronic liver
diseases. (abst 2007)
http://www.ncbi.nlm.nih.gov/pubmed/17952109
--
That's just a few out of pages of info on the liver and cannabis haha.. read up! It is organic medicine. Safe!
http://www.michiganmedicalmarijuanaclub.org/Grannys List January 2013.pdf
--
The endocannabinoid system in chronic liver disease (full
2005)
http://www.medigraphic.com/pdfs/hepato/ah-2005/ah054c.pdf
(Marijuana/Hash) Endocannabinoids and liver disease
review (full 2005)
http://www.natap.org/2005/HCV/091905_01.htm
Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and
contributes to diet induced obesity
(full 2005)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1087161/?tool=pmcentrez
Roles of anandamide in the hepatic microcirculation in cirrhotic rats
(full 2005)
http://ajpgi.physiology.org/content/290/2/G328.full?sid=c16d770d-cd17-48c9-bbde-26f38f5eeb67
The Ffa Receptor Gpr40 Links Hyperinsulinemia, Hepatic Steatosis, and Impaired Glucose Homeostasis in Mouse.
(abst 2005)
http://www.ncbi.nlm.nih.gov/pubmed/16054069
Antifibrogenic role of the cannabinoid receptor CB2 in the liver.
(abst 2005)
http://www.ncbi.nlm.nih.gov/pubmed/15765409
CB2 receptors as new therapeutic targets for liver diseases (full 2007)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219531/?tool=pubmed
Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion
injury by attenuating oxidativestress, inflammatory response, and apoptosis
(full 2007)
http://www.jleukbio.org/cgi/content/full/82/6/1382
Cannabinoids ameliorate cerebral dysfunction following liver failure via AMP-activatedprotein kinase
(full 2007)
http://hmg.oxfordjournals.org/cgi/content/full/14/22/3389
Endocannabinoids acting at CB1 receptors mediate the cardiac contractile dysfunction invivo in cirrhotic rats
(full 2007)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2225474/?tool=pmcentrez
Pivotal Advance: Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis (full 2007)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2225476/?tool=pmcentrez
Anandamide inhibits cholangiocyte hyperplastic proliferation via activation of
thioredoxin 1/redox factor 1 and AP-1 activation (full 2007)
http://ajpgi.physiology.org/content/294/2/G506.full
Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury
(full 2007)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228252/?tool=pmcentrez
Cannabinoid receptors as new targets of antifibrosing strategies during chronic liver
diseases. (abst 2007)
http://www.ncbi.nlm.nih.gov/pubmed/17952109
--
That's just a few out of pages of info on the liver and cannabis haha.. read up! It is organic medicine. Safe!